Trehalose
Sponsors
the Affiliated Wuxi People's Hospital to Nanjing Medical University, Consorcio Centro de Investigación Biomédica en Red (CIBER), Mashhad University of Medical Sciences, Samsung Medical Center, Bioblast Pharma Ltd.
Conditions
Acute Coronary SyndromeAlzheimer DiseaseAmyotrophic Lateral SclerosisBipolar DepressionBipolar DisorderCataractCrohn Disease (CD)Dry Eye
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease
NCT05355064
Start: 2022-05-31End: 2023-05-31Target: 20Updated: 2022-05-02
The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
NCT05990712
Start: 2023-09-01End: 2024-01-01Target: 68Updated: 2023-08-14
Unknown Phase
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
CompletedNCT03738358
Start: 2016-06-30End: 2018-03-20Updated: 2019-01-30
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3
NCT04399265
Start: 2020-02-24End: 2023-06-30Target: 20Updated: 2022-08-16
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3
CompletedNCT04426149
Start: 2018-03-07End: 2018-09-07Updated: 2020-06-11
Intermediate-Sized Expanded Access Study
NCT05597436
Updated: 2025-09-02
Effects of probiotics and prebiotics on protein-bound uremic toxins and intestinal microflora in peritoneal dialysis patients
Active, not recruitingChiCTR2400087407
Start: 2024-08-01Updated: 2024-07-29